| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00403-014-1454-X |
| P698 | PubMed publication ID | 24573469 |
| P50 | author | Angelica A Saetta | Q53850095 |
| P2093 | author name string | Efstratios Patsouris | |
| Issidora Papassideri | |||
| Christina Vlachou | |||
| Angeliki Stamatelli | |||
| Kiriaki Aroni | |||
| P2860 | cites work | Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer | Q46425815 |
| The death-associated protein kinases: structure, function, and beyond | Q24292704 | ||
| Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands | Q24631957 | ||
| hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis | Q24670424 | ||
| The ABC of APC | Q28205388 | ||
| Downregulation of expression of a novel cadherin molecule, T-cadherin, in basal cell carcinoma of the skin | Q28218227 | ||
| Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types | Q28248276 | ||
| Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer | Q28253304 | ||
| RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors | Q28258450 | ||
| Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma | Q29615026 | ||
| Gene silencing in cancer in association with promoter hypermethylation | Q29617274 | ||
| Epigenetic silencing contributes to frequent loss of the fragile histidine triad tumour suppressor in basal cell carcinomas | Q30319925 | ||
| Analysis of 14-3-3sigma expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma | Q30977955 | ||
| CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future | Q33337445 | ||
| MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome | Q34253639 | ||
| Epigenetic changes in Basal Cell Carcinoma affect SHH and WNT signaling components | Q34532204 | ||
| DNA-methylation profiling distinguishes malignant melanomas from benign nevi | Q34775571 | ||
| Age-related epigenetic changes and the immune system | Q35571297 | ||
| Application of a methylation gene panel by quantitative PCR for lung cancers | Q36047712 | ||
| Correlation between BRAF mutation and promoter methylation of TIMP3, RARβ2 and RASSF1A in thyroid cancer | Q36149220 | ||
| Aberrant DNA methylation in cutaneous malignancies. | Q36279332 | ||
| Basal cell carcinoma: biology, morphology and clinical implications | Q36381921 | ||
| The RASSF1A tumor suppressor | Q36945316 | ||
| DNA Demethylating Agents and Epigenetic Therapy of Cancer | Q37797705 | ||
| Hedgehog signaling in skin cancers | Q37852292 | ||
| Molecular pathology of melanocytic tumors | Q38171606 | ||
| Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis. | Q40583206 | ||
| BRAF mutation-specific promoter methylation of FOX genes in colorectal cancer | Q41056167 | ||
| Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas | Q42473020 | ||
| PTCH promoter methylation at low level in sporadic basal cell carcinoma analysed by three different approaches | Q42477202 | ||
| Expression of mismatch repair enzymes, hMLH1 and hMSH2 is not associated with microsatellite instability and P53 protein accumulation in basal cell carcinoma | Q42481128 | ||
| Sun exposure related methylation in malignant and non-malignant skin lesions | Q42491211 | ||
| Absence of BRAF gene mutation in non-melanoma skin tumors | Q42495165 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 561-569 | |
| P577 | publication date | 2014-02-27 | |
| P1433 | published in | Archives of Dermatological Research | Q18616385 |
| P1476 | title | Epigenetic alterations in sporadic basal cell carcinomas | |
| P478 | volume | 306 |
Search more.